Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Salmonellosis

  • Author: Alena Klochko, MD; Chief Editor: Michael Stuart Bronze, MD  more...
 
Updated: Oct 08, 2015
 

Background

Salmonellae are gram-negative motile bacilli. The genus Salmonella, which belongs to the family Enterobacteriaceae, was named after Daniel E. Salmon, an American veterinarian who first isolated Salmonella choleraesuis from pigs with hog cholera in 1884.[1]

As with the closely related bacterium Escherichia coli, salmonellae are potential enteric pathogens and a leading cause of bacterial foodborne illness. In addition, Salmonella species have been implicated in a spectrum of other diseases, including enteric or typhoid fever (primarily Salmonella typhi and Salmonella paratyphi), bacteremia, endovascular infections, focal infections (eg, osteomyelitis), and enterocolitis (typically Salmonella typhimurium, Salmonella enteritidis, and Salmonella heidelberg).

Salmonellae can be isolated in the microbiology laboratory using numerous low-selective media (MacConkey agar, deoxycholate agar), intermediate-selective media (Salmonella-Shigella [SS] agar, Hektoen [HE] agar), and highly selective media (selenite agar with brilliant green). Salmonellae are oxidase-negative and predominantly lactose-negative. Fewer than 1% of nontyphoidal Salmonella isolates are lactose-positive (pink on MacConkey agar), but most produce hydrogen sulfide, which is detectable on HE or SS agar. As facultative anaerobes, they grow well both in bottles of standard automated systems for blood cultures and on culture media routinely used for urine, tissue, and respiratory cultures.[2] Individual isolates can then be distinguished with serogrouping, pulsed-field gel electrophoresis, and bacteriophage serotyping techniques.

Nomenclature and classification

The nomenclature and classification of Salmonella species have been changed and restructured multiple times. Traditionally, Salmonella species were named in accordance with the Kaufmann-White typing system, defined by different combinations of somatic O, surface Vi, and flagellar H antigens. In 2005, Salmonella enterica finally gained official approval as the type species of the genus Salmonella. The genus Salmonella also contains the species Salmonella bongori and Salmonella subterranean, which was recognized in 2005.[3]

Currently, Salmonella species have the serologically defined names appended as serovars or serotypes. For instance, the current nomenclature of S typhi is S enterica serovar Typhi. S enterica is preferred over confusing name S choleraesuis, which is also the name of a commonly isolated serotype.[4] To date, more than 2500 serovars of S enterica have been described. Certain serovars are host-restricted, while others have a broad host range.[5]

Next

Pathophysiology

The transmission of salmonellae to a susceptible host usually occurs via consumption of contaminated foods. The most common sources of salmonellae include beef, poultry, and eggs. In one recent estimate, consumption of egg shell fragments contaminated with S enteritidis was responsible for approximately 182,060 cases of enteritis in the United States in the year 2000. Improperly prepared fruits, vegetables, dairy products, and shellfish have also been implicated as sources of Salmonella.

In the spring of 2008, 1442 persons across 43 states developed infection with S enterica serotype Saintpaul, with the same genetic fingerprint linking contaminated jalapeno and serrano peppers as a source of infection.[6] Almost any type food product could serve a source for infection, including peanut butter, as seen during a recent outbreak of more than 600 cases.[7] Powdered infant formula has been implicated in two consecutive large outbreaks of S enterica serotype Agona among infants in France.[8]

In addition, human-to-human and animal-to-human transmissions can occur. For example, amphibian and reptile exposures are associated with approximately 74,000 Salmonella infections annually in the United States. Salmonellosis outbreaks have also been associated with handling chicks, ducklings, kittens, and hedgehogs.[9, 10, 11, 12, 13, 14] Recently, a study of 28 cases of Styphimurium identified pet rodents as a previously unrecognized source of human Salmonella infection.[15]

Although the infectious dose varies among Salmonella strains, a large inoculum is thought to be necessary to overcome stomach acidity and to compete with normal intestinal flora. Large inocula are also associated with higher rates of illness and shorter incubation periods. In general, about 106 bacterial cells are needed to cause infection. Low gastric acidity, which is common in elderly persons and among individuals who use antacids, can decrease the infective dose to 103 cells, while prior vaccination can increase the number to 109 cells.[16]

After ingestion, infection with salmonellae is characterized by attachment of the bacteria by fimbriae or pili to cells lining the intestinal lumen. Salmonellae selectively attach to specialized epithelial cells (M cells) of the Peyer patches. The bacteria are then internalized by receptor-mediated endocytosis and transported within phagosomes to the lamina propria, where they are released. Once there, salmonellae induce an influx of macrophages (typhoidal strains) or neutrophils (nontyphoidal strains).

The Vi antigen of S typhi is important in preventing antibody-mediated opsonization and complement-mediated lysis. Through the induction of cytokine release and via mononuclear cell migration, S typhi organisms spread through the reticuloendothelial system, mainly to the liver, spleen, and bone marrow. Within 14 days, the bacteria appear in the bloodstream, facilitating secondary metastatic foci (eg, splenic abscess, endocarditis). In some patients, gallbladder infection leads to long-term carriage of S typhi or S paratyphi in bile and secretion to the stool.[17] As a rule, infection with nontyphoidal salmonellae generally precipitates a localized response, while S typhi and other especially virulent strains invade deeper tissues via lymphatics and capillaries and elicit a major immune response.

Virulence factors of salmonellae are complex and encoded both on the organism's chromosome and on large (34-120 kd) plasmids. Some areas of active investigation include the means by which salmonellae attach to and invade the intestine, survive within phagosomes, effect a massive efflux of electrolytes and water into the intestinal lumen, and develop drug resistance. Several Salmonella pathogenicity islands have been identified that mediate uptake of the bacteria into epithelial cells (type III secretion system [TTSS]), nonphagocytic cell invasion (Salmonella pathogenicity-island 1 [SPI-1]), and survival and replication within macrophages (Salmonella pathogenicity-island 2 [SPI-2], phoP/phoQ).

The severity of illness in individuals with salmonellosis is determined not only by the virulence factors of the infecting strain but also by host properties. In a recent study of 129 nonfecal Salmonella isolates at the Massachusetts General Hospital, the most common risk factors were found to be corticosteroid use, malignancy, diabetes, HIV infection, prior antimicrobial therapy, and immunosuppressive therapy.[2]

Sickle cell disease, malaria, schistosomiasis, bartonellosis, and pernicious anemia have been mentioned in the literature as other comorbidities that predispose to salmonellosis. Infants are at a high risk of developing CNS infection as a result of Salmonella bacteremia. Specific anatomical sites, such as an altered urinary or biliary tract, atherosclerotic aorta, or endovascular devices may facilitate persistent focal Salmonella infection.

Previous
Next

Epidemiology

Frequency

United States

The incidence of Salmonella infections in the United States has been stable since 2004 but has decreased approximately 8% from 1996-1998 levels.[18] In 2007, the reported annual incidence of salmonellosis was 14.9 cases per 100,000 population.[18] The true annual burden of nontyphoidal Salmonella infection in the United States is calculated to be 520 cases per 100,000 population, compared with 13.4 laboratory-confirmed cases per 100,000 population per year. This reflects an estimate of approximately 38.6 cases of nontyphoidal Salmonella infection for each culture-confirmed case.[19]

From February 1 to May 31, 2012, 22 cases (20 cases in 13 states and 2 cases in Canada) of human infections with S infantis were reported. Epidemiologic investigations found that 83% reported dog contacts, and, of the 11 patients who recalled types of dog food, 8 reported brands produced by Diamond Pet Foods.[20]

In 2007, 364 Salmonella infections (5.4% of the overall reported cases) were associated with salmonellosis outbreaks, similar to the proportion in previous years. Four large multistate outbreaks of Salmonella infections that included FoodNet sites were investigated in 2007: an outbreak of S enterica serotype Tennessee infections caused by contaminated peanut butter, an outbreak of S enterica serotype I 4,5,12:i:- caused by contaminated frozen pot pies, an outbreak of S enterica serotype Wandsworth and Styphimurium infections attributed to a puffed vegetable snack, and an outbreak of S paratyphi B variant Java associated with exposure to turtles.[18]

In 2008-2009, a nationwide outbreak of S typhimurium was traced to peanut products and frozen chicken products. Because the contaminated peanuts were used to make a variety of products that were distributed across the country, this outbreak highlighted how difficult it can be to trace the source of an outbreak.[21]

Although the prevalence of Salmonella infections is highest in children, salmonellosis outbreaks are common among individuals who are institutionalized and residents of nursing homes. Approximately one case of paratyphoid fever is reported per every four of typhoid fever. Typhoid fever is increasingly associated with travel to developing countries (currently 72% of approximately 400 cases per year). Common sources of infection include India (30%), Pakistan (13%), Mexico (12%), Bangladesh (8%), Philippines (8%), and Haiti (5%).[22]

International

The incidence of salmonellosis has markedly increased in many countries; however, a paucity of good surveillance data exists. In 2000, approximately 21.6 million worldwide cases of typhoid fever caused 216,500 deaths.[23] The incidence of typhoid fever in south-central Asia, Southeast Asia, and, possibly, southern Africa was high (>100 cases per 100,000 population per year). The rest of Asia, Africa, Latin America, and Oceania (except for Australia and New Zealand) typically see intermediate rates of typhoid fever (10-100 cases per 100,000 population), while the incidence is low in the other parts of the world (< 10 cases per 100,000 population). In countries where typhoid fever is endemic, most cases of the disease occur in children aged 5-19 years and young adults.[24]

Mortality/Morbidity

Infection with nontyphoidal salmonellae typically produces a self-limiting gastroenteritis, and dehydrated patients occasionally require hospitalization. Death is rare. The mortality rate associated with S enteritidis infection outbreaks in the United States from 1985-1991 was 0.4%. Case-fatality rates were 70 times higher in nursing homes and hospitals. Mortality rates associated with typhoid fever are similarly low in the United States (< 1%), but mortality rates of 10-30% have been reported in some Asian and African countries. Between 1996 and 1999, an estimated 1.4 million nontyphoidal Salmonella infections occurred in the United States, with an estimated 15,000 hospitalizations and 400 deaths annually. A related study during the same period found that 22% of people infected with nontyphoidal Salmonella required hospitalization, with an annual incidence of 0.08 deaths per 100,000 population.

Development of bacteremia worsens the prognosis. In the 1990s, at Massachusetts General Hospital, 18% of 45 patients with Salmonella bacteremia died.[2]

Although uncommon, extraintestinal complications of salmonellosis caused by seeding of other organs are associated with increased mortality rates. Such complications include endocarditis, vascular infections, cholecystitis, hepatic and splenic abscesses, urinary tract infections, pneumonia or empyema, meningitis, septic arthritis, and osteomyelitis. Half of all Salmonella CNS infections are fatal.[2]

Multidrug-resistant typhoid fever in childhood is associated with increased risk of mortality, especially in infancy,[24] possibly because of the increased virulence of multidrug-resistant S typhi, as well as a higher number of circulating bacteria.[25]

Race

Salmonellosis has no racial predilection.

Sex

Salmonellosis has no sexual predilection.

Age

The incidence of salmonellosis in the United States is greatest among children younger than 5 years (61.8 per 100,000 people), with a peak among those younger than 1 year. Infants and people older than 60 years are most susceptible and tend to have more severe infections. In one 4-year surveillance study, 47% of people hospitalized with nontyphoidal Salmonella infections were older than 60 years.

Previous
 
 
Contributor Information and Disclosures
Author

Alena Klochko, MD Infectious Disease Physician, Orlando Health, Florida

Disclosure: Nothing to disclose.

Coauthor(s)

Mark R Wallace, MD, FACP, FIDSA Clinical Professor of Medicine, Florida State University College of Medicine; Clinical Professor of Medicine, University of Central Florida College of Medicine

Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, Florida Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

John L Brusch, MD, FACP Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance

John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, Oklahoma State Medical Association, Southern Society for Clinical Investigation, Association of Professors of Medicine, American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

Mary D Nettleman, MD, MS MACP, Professor and Chair, Department of Medicine, Michigan State University College of Human Medicine

Mary D Nettleman, MD, MS is a member of the following medical societies: American College of Physicians, Association of Professors of Medicine, Central Society for Clinical and Translational Research, Infectious Diseases Society of America, Society of General Internal Medicine

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Michael Zapor, MD, PhD, and previous coauthor David P Dooley, MD, to the development and writing of this article.

References
  1. Kim AY, Goldberg MB, Rubin RH. Salmonella infections. Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 3rd ed. Lippincott Williams and Wilkins; 2004. 68.

  2. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001 Jan 15. 32(2):263-9. [Medline].

  3. Su LH, Chiu CH. Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J. May-Jun 2007. 30 (3):210-9. [Medline].

  4. Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B. Salmonella nomenclature. J Clin Microbiol. 2000 Jul. 38(7):2465-7. [Medline].

  5. Grassl GA, Finlay BB. Pathogenesis of enteric Salmonella infections. Curr Opin Gastroenterol. 2008 Jan. 24(1):22-6. [Medline].

  6. Investigation of outbreak of infections caused by Salmonella saintpaul. Update for August 2008. Available at http://www.cdc.gov/salmonella/saintpaul/. Accessed: 10/29/2008.

  7. Crum-Cianflone NF. Salmonellosis and the gastrointestinal tract: more than just peanut butter. Curr Gastroenterol Rep. Aug 2008. 10 (4):424-31. [Medline].

  8. Brouard C, Espie E, Well FX , Kerouanton A, Brisabois A, Forgue AM, et al. Two consequtive large outbreaks of Salmonella enterica serotype Agona infections in infants linked to the consumption of powdered infant formula. Pediatr Infect Dis J. Feb 2007. 26(2):148-52. [Medline].

  9. Centers for Disease Control and Prevention. From the Centers for Disease Control and Prevention. African pygmy hedgehog-associated salmonellosis--Washington, 1994. JAMA. 1995 Jul 26. 274(4):294. [Medline].

  10. Mermin J, Hutwagner L, Vugia D, et al. Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clin Infect Dis. 2004 Apr 15. 38 Suppl 3:S253-61. [Medline].

  11. Outbreaks of multidrug-resistant Salmonella typhimurium associated with veterinary facilities--Idaho, Minnesota, and Washington, 1999. MMWR Morb Mortal Wkly Rep. 2001 Aug 24. 50(33):701-4. [Medline]. [Full Text].

  12. Reptile-associated salmonellosis--selected states, 1998-2002. MMWR Morb Mortal Wkly Rep. 2003 Dec 12. 52(49):1206-9. [Medline]. [Full Text].

  13. Salmonellosis associated with chicks and ducklings--Michigan and Missouri, Spring 1999. MMWR Morb Mortal Wkly Rep. 2000 Apr 14. 49(14):297-9. [Medline]. [Full Text].

  14. Woodward DL, Khakhria R, Johnson WM. Human salmonellosis associated with exotic pets. J Clin Microbiol. 1997 Nov. 35(11):2786-90. [Medline]. [Full Text].

  15. Swanson SJ, Snider C, Braden CR, Boxrud D, Wunschmann A, Rudroff JA, et al. Multidrug resistant salmonella enterica serotype Typhimurium associated with pet rodents. N Engl J Med. January 4, 2007. 356:21-8. [Medline]. [Full Text].

  16. World Health Organization Communicable Disease Surveilance and Response. Vaccines and Biologicals. Background document: The diagnosis, treatment and prevention of typhoid fever. Available at www.who.int/vaccines-documents/DocsPDF03/www740.pdf. Accessed: 10/29/08.

  17. Meltzer E, Schwartz E. Enteric fever: an Israeli perspective. Isr Med Assoc J. 2007 Oct. 9(10):736-41. [Medline].

  18. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--10 states, 2007. MMWR Morb Mortal Wkly Rep. 2008 Apr 11. 57(14):366-70. [Medline].

  19. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004 Apr 15. 38 Suppl 3:S127-34. [Medline].

  20. Centers for Disease Control and Prevention (CDC). Notes from the field: Human Salmonella infantis infections linked to dry dog food--United States and Canada, 2012. MMWR Morb Mortal Wkly Rep. 2012 Jun 15. 61(23):436. [Medline].

  21. Cavallaro E, Date K, Medus C, Meyer S, Miller B, Kim C, et al. Salmonella typhimurium infections associated with peanut products. N Engl J Med. 2011 Aug 18. 365(7):601-10. [Medline].

  22. Linam WM, Gerber MA. Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J. 2007 Aug. 26(8):747-8. [Medline].

  23. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. May 2004. 82 (5):346-53. [Medline].

  24. Bhan MK, Bahl R, Bhatnagar S. Typhoid and parattyphoid fever. Lancet. Aug 2005. 366:749-62. [Medline]. [Full Text].

  25. Hathout S el-D. Relation of schistosomiasis to typhoid fever. J Egypt Public Health Assoc. 45. 1970:145-56. [Medline].

  26. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child. 1996. 75:214-7. [Medline]. [Full Text].

  27. Ali G, Rashid S, Kamli MA, Shah PA, Allaqaband GQ. Spectrum of neuropsychiatric complications in 791 cases of typhoid fever. Trop Med Int Health. 1997. 2:314-318. [Medline].

  28. Prabha A, Mohanan, Pereira P, Raghuveer CV. Myocarditis in enteric fever. Indian J Med Sci. 1995. 49:28-31. [Medline].

  29. Gasem MH, Keuter M, Dolmans WM, Van DerVen-Jongekriig J, Djokomoeljanto R, Van Der Meer JW. Persistence of Salmonellae in blood and bone marrow randomized controlled trial comparing ciprofloxacin and chloramphenicol treatment against enteric fever. Antimicrob Agents Chemother. May 2003. 47:1727-31. [Medline]. [Full Text].

  30. Nakamura S, Iida M, Tominaga M, et al. Salmonella colitis: Assessment with double-contrast barium enema examination in seven patients. Radiology. Aug/1992. 184:537-540. [Medline].

  31. Balthazar EJ, Charles HW, Megibow AJ. Salmonella- and shigella-induced ileitis: CT findings in four patients. J Comput Assist Tomogr. May/1996. 20:375-378. [Medline].

  32. Puylaert JB, Van der Zant FM, Mutsaers JA. Infectious ileocecitis caused by Yersinia, Campylobacter, and Salmonella: clinical, radiological and US findings. Eur Radiol. 1997. 7(1):3-9. [Medline].

  33. Lee WK, Mossop PJ, Little AF, et al. Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics. 2008 Nov-Dec. 28(7):1853-68. [Medline].

  34. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ. Jul 2006. 333:78-82. [Medline]. [Full Text].

  35. Shirakava T, Acarya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Kathmandu, Nepal, in 2003. Diagn Microbiol Infect Dis. Apr 2006. 54:299-303. [Medline].

  36. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011 Mar. 55(3):1148-54. [Medline].

  37. Ercis S, Erdem B, Hasçelik G, Gür D. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey. Jpn J Infect Dis. 2006 Apr. 59(2):117-9. [Medline]. [Full Text].

  38. Hakanen A, Kotilanien P, Jalava J, et al. Detection of decreased fluoroquinolone susceptibility in Sal.onella and validation of nalidixic acid screening test. J Clin Microbiol. 1999. 37:3572-77. [Medline]. [Full Text].

  39. Beeching NJ, Parry CM. Outpatient treatment of patients with enteric fever. Lancet Infect Dis. 2011 Jun. 11(6):419-21. [Medline].

  40. Coughlin LB, McGuigan J, Haddad NG, Mannion P. Salmonella sepsis and miscarriage. Clin Microbiol Infect. 2003 Aug. 9(8):866-8. [Medline].

  41. Gyang A, Saunders M. Salmonella Mississippi: a rare cause of second trimester miscarriage. Arch Gynecol Obstet. 2008 May. 277(5):437-8. [Medline].

  42. Oskoui R, Davis W, Gomez M. Salmonella aortitis: a report of successfully treated case with a comprehensive review of the literature. Arch Intern Med. Feb 1993. 153:517-25. [Medline].

  43. Nunes AP, Marques A, Marchado C, Meirelaes N, Sobrinho G, et al. Tiphymurium Salmonella Aortitis. Rev Port Cir Cardiotorac Vasc. Jul-Sept 2007. 14:167-71. [Medline].

  44. Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. Jul 2007. 3:CD001261. [Medline].

  45. Chen PL, Lee CC, Li CY, et al. A simple scoring algorithm predicting vascular infections in adults with nontyphoid Salmonella bacteremia. Clin Infect Dis. 2012 Jul. 55(2):194-200. [Medline].

  46. Workman MR, Philpott-Howard J, Bragman S, Brito-Babapulle F, Bellingham AJ. Emergence of ciprofloxacin resistance during treatment of Salmonella osteomyelitis in three patients with sickle cell disease. J Infect. 1996 Jan. 32(1):27-32. [Medline].

  47. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005 Jan 6. 352(1):39-47. [Medline].

  48. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children aged less than 5 years. Lancet. 1999 Aug 28. 354(9180):734-7. [Medline].

  49. Crum-Cianflone NF. Salmonellosis and the gastrointestinal tract: more than just peanut butter. Curr Gastroenterol Rep. Aug 2008. 10 (4):424-31. [Medline].

  50. Miller SI, Pegues DA. Salmonella species, including Salmonella typhi. Mandell, et al, ed. Principles and Practices of Infectious Diseases. 5th ed. 2000. Vol 2: 2344-62.

  51. Schroeder CM, Naugle AL, Schlosser WD, et al. Estimate of illnesses from Salmonella enteritidis in eggs, United States, 2000. Emerg Infect Dis. 2005 Jan. 11(1):113-5. [Medline].

  52. Freeman R, Dabrera G, Lane C, Adams N, Browning L, Fowler T, et al. Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013. Epidemiol Infect. 2015 Oct 1. 1-8. [Medline].

  53. Williams S, Markey P, Harlock M, Binns P, Gaggin J, Patel M. Individual and household-level risk factors for sporadic salmonellosis in children. J Infect. 2015 Sep 28. [Medline].

 
Previous
Next
 
Rose spots on abdomen of a patient with typhoid fever due to the bacterium Salmonella typhi. Courtesy of CDC/Armed Forces Institute of Pathology, Charles N. Farmer.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.